| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 02/21/2007 | EP1753718A1 3-amino-2-phenylpyrrolidine derivatives |
| 02/21/2007 | EP1753421A2 Arylsulfonamides and uses as hydroxysteroid dehydrogenase |
| 02/21/2007 | EP1567488B1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 02/21/2007 | EP1551797B1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 02/21/2007 | EP1356811B1 Combination of three substances for the prevention or treatment of arthritis |
| 02/21/2007 | EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/21/2007 | CN1918145A Amino heterocyclic modulators of chemokine receptor activity |
| 02/21/2007 | CN1918121A Pyrrole-3-carboxamide derivatives for the treatment of obesity |
| 02/21/2007 | CN1918120A Method for purifying n-methyl-2-pyrrolidone |
| 02/21/2007 | CN1918119A Bicycloester derivative |
| 02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 02/21/2007 | CN1917873A Diurea derivatives |
| 02/21/2007 | CN1917763A N-(2-(hydroxymethyl) phenyl)-1h-pyrazole-4-carboxamide derivatives and related compounds as microbicidal active ingredients for phyto-protection and the protection of materials |
| 02/21/2007 | CN1916760A Acid-producing agent, sulfonic acid, sulfonic acid derivative and radiation-sensitive resin composition |
| 02/21/2007 | CN1915964A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/21/2007 | CN1915496A Application of load type catalyst in synthesizing N phenyl maleimide |
| 02/21/2007 | CN1301249C Clausend wanpi acidamine C5 hydroxy derivative and N substituted derivative, its preparation method and its medicinal composition and use |
| 02/20/2007 | US7179923 N-sulfonylaminocarbonyl containing compounds |
| 02/20/2007 | US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179835 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 02/20/2007 | US7179825 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179819 Benzyl -urea, -thiourea, or -guanidine derivatives that inhibit the binding of ligands to alpha 4 beta 1 integrin (VLA-4); for therapy and prophylaxis of pathologies associated with VLA-4 mediated cell adhesion, such as inflammatory and autoimmune diseases, and tumor metastasis |
| 02/20/2007 | US7179806 Δ1-pyrrolines used as pesticides |
| 02/20/2007 | US7179794 Antibiotics; bactericides |
| 02/20/2007 | CA2375225C Mutual salt of amlodipine and atorvastatin |
| 02/15/2007 | WO2007019255A2 Salts of vildagliptin |
| 02/15/2007 | WO2007018514A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 02/15/2007 | WO2007018508A1 Novel m3 muscarinic acetycholine receptor antagonists |
| 02/15/2007 | WO2007018439A1 Conducting polymers and uses thereof |
| 02/15/2007 | WO2006020060A3 Iap binding compounds |
| 02/15/2007 | WO2005092897A3 2,4,6-phenylsubstituted cyclic ketoenoles |
| 02/15/2007 | US20070037988 Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof |
| 02/15/2007 | US20070037973 reacting a cyclic alpha , beta -unsaturated ketone compound with a nitroso compound in the presence of a proline-based catalyst to provide 7-Phenyl-6-oxa-7-aza-bicyclo[3.2.2]nonan-9-one or derivatives; catalytic asymmetric O-nitroso Aldol/Michael reaction |
| 02/15/2007 | US20070037823 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 02/15/2007 | US20070037806 Pyrrolidine derivatives as oxytocin antagonists |
| 02/15/2007 | US20070037752 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 02/15/2007 | CA2617327A1 Salts of vildagliptin |
| 02/14/2007 | EP1751192A1 Cross-linked antibodies |
| 02/14/2007 | EP1751108A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 02/14/2007 | EP1751101A1 Substituted 5-aminomethyl-1h-pyrrol-2-carbxylic acid amides |
| 02/14/2007 | EP1751100A1 Anti-tubulin acting arylpyrrol, arylfulran and arylthiopene derivatives, method for the preparation and use thereof as an antimitotic |
| 02/14/2007 | EP1751099A1 Cis pyrrolidinyl derivatives and their uses |
| 02/14/2007 | EP1751098A1 Trans pyrrolidinyl derivatives and their pharmaceutical use |
| 02/14/2007 | EP1435943B1 Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug for treating dyskinesia |
| 02/14/2007 | EP1392355B1 Use of proteasome inhibitors to treat dry eye disorders |
| 02/14/2007 | EP1063982B1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
| 02/14/2007 | EP0820283B1 Lactacystin analogs |
| 02/14/2007 | CN1914509A Time-temperature indicator based on valence isomerizations |
| 02/14/2007 | CN1914224A HCV NS-3 serine protease inhibitors |
| 02/14/2007 | CN1914152A New compounds, methods for their preparation and use thereof |
| 02/14/2007 | CN1911929A Meso position-tetra phenyl tetra phenanthro porphyrin derivetive and its preparation method |
| 02/14/2007 | CN1300109C Process for recovery of N-methylpyrrolidone from lithium cell discharge gas |
| 02/14/2007 | CN1300108C Method for synthesizing 1-methyl-2-amine ethyl pyrrolidine |
| 02/14/2007 | CN1299677C 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 02/13/2007 | US7176323 Process for the production of γ-keto acetals |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors |
| 02/13/2007 | US7176228 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials |
| 02/13/2007 | CA2359510C .omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 02/13/2007 | CA2112420C N-arylhydrazine derivatives as insecticidal and acaricidal agents |
| 02/08/2007 | WO2007016385A2 Use of substituted 5-amino-1h-pyrrole-2-carbonitrile derivatives as progesterone receptor modulators |
| 02/08/2007 | WO2007016212A1 Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof |
| 02/08/2007 | WO2007016211A1 Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof |
| 02/08/2007 | WO2007015824A2 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 02/08/2007 | WO2007015805A1 1-amino linked compounds |
| 02/08/2007 | WO2007015567A1 Cyclic amine compound |
| 02/08/2007 | WO2007015533A1 Amidine compound and herbicide |
| 02/08/2007 | WO2007014607A1 Quadratic acid derivatives in the form of a protein kinase inhibitors |
| 02/08/2007 | WO2006045119A3 Improved inhibitors for the soluble epoxide hydrolase |
| 02/08/2007 | US20070032665 Preparation of atorvastatin calcium form i |
| 02/08/2007 | US20070032664 Making intermediates such as ((4R,6R)-6-{2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-ethyl}-2-phenyl-[1,3]dioxan-4-yl)-acetic acid methyl ester for the synthesis of calcium atorvastatin (Lipitor(reg)) |
| 02/08/2007 | US20070032663 Intermediate in the synthesis of calcium atorvastatin (Lipitor(reg)) comprising an amine salt of a carboxylic acid, for example 2-(morpholinocarbonyl)ethylamine, phenylacetic acid salt |
| 02/08/2007 | US20070032662 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrole-3-carboxylic acid and phenylamide |
| 02/08/2007 | US20070032542 Process for the preparation of enantiopure pyrrolidin-2-one derivatives |
| 02/08/2007 | US20070032541 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
| 02/08/2007 | US20070032539 Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives serving as pesticides |
| 02/08/2007 | US20070032526 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 02/08/2007 | US20070032524 Diphenylmethyl compounds useful as muscarinic receptor antagonists |
| 02/08/2007 | CA2617256A1 Cyclic amine compound |
| 02/08/2007 | CA2616682A1 Squaric acid derivatives as protein kinase inhibitors |
| 02/08/2007 | CA2615666A1 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 02/08/2007 | CA2613518A1 Use of substituted 5-amino-1h-pyrrole-2-carbonitrile derivatives as progesterone receptor modulators |
| 02/08/2007 | CA2613484A1 Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof |
| 02/08/2007 | CA2612977A1 Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof |
| 02/07/2007 | EP1749002A1 Pyrrole or imidazole amides for treating obesity |
| 02/07/2007 | EP1748981A1 Process for the preparation of optically pure 4-hydroxy-2-oxo-1-pyrrolidine acetamide |
| 02/07/2007 | EP1748980A1 Pyrrolidine derivatives as cb1-receptor antagonists |
| 02/07/2007 | EP1626716B1 Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity |
| 02/07/2007 | EP1606255A4 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/07/2007 | CN1910175A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 02/07/2007 | CN1910174A Indolylmaleimide derivatives |
| 02/07/2007 | CN1910173A Indolylmaleimide derivatives as PKC inhibitors |
| 02/07/2007 | CN1910147A Malononitrile compound and use thereof |
| 02/07/2007 | CN1910146A Aspartates useful as components in coating compositions and their preparation |
| 02/07/2007 | CN1910145A Pyrrolidine derivatives acting as CCR3-receptor antagonists |
| 02/07/2007 | CN1910141A Diamino alcohols and their use as renin inhibitors |
| 02/07/2007 | CN1909897A Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease |
| 02/07/2007 | CN1907984A Compound for preparing intermediate for synthesis of atorvastatin calcium |